RAPT · Categories · Form 4

RAPT - SEC Form 4 insider transactions

RAPT Therapeutics Inc. (RAPT) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for RAPT

• 96d
  Director Lyons-Williams Lori closing all direct ownership in the company (SEC Form 4)

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 96d
  Director Gray Mary Ann closing all direct ownership in the company (SEC Form 4)

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 96d
  Director Giordano Michael F closing all direct ownership in the company (SEC Form 4)

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 96d
  Director Dombkowski Ashley L. closing all direct ownership in the company (SEC Form 4)

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 96d
  CHIEF FINANCIAL OFFICER Young Rodney Kb closing all direct ownership in the company (SEC Form 4)

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 96d
  CHIEF SCIENTIFIC OFFICER Brockstedt Dirk G. closing all direct ownership in the company (SEC Form 4)

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 96d
  PRESIDENT AND CEO Wong Brian Russell closing all direct ownership in the company (SEC Form 4)

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 96d
  Director Kozick Linda closing all direct ownership in the company (SEC Form 4)

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 96d
  Director Braunstein Scott closing all direct ownership in the company (SEC Form 4)

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 126d
  Director Braunstein Scott was granted 4,956 shares (SEC Form 4)

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 126d
  Director Giordano Michael F was granted 4,956 shares (SEC Form 4)

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 126d
  Director Gray Mary Ann was granted 4,956 shares (SEC Form 4)

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 126d
  Director Lyons-Williams Lori was granted 4,956 shares (SEC Form 4)

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 126d
  Director Kozick Linda was granted 4,956 shares (SEC Form 4)

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 126d
  Director Dombkowski Ashley L. was granted 4,956 shares (SEC Form 4)

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 343d
  SEC Form 4 filed by Director Dombkowski Ashley L.

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 349d
  SEC Form 4 filed by Director Braunstein Scott

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 349d
  SEC Form 4 filed by CHIEF MEDICAL OFFICER Ho William

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 349d
  SEC Form 4 filed by PRESIDENT AND CEO Wong Brian Russell

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 349d
  SEC Form 4 filed by CHIEF FINANCIAL OFFICER Young Rodney Kb

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 349d
  SEC Form 4 filed by CHIEF SCIENTIFIC OFFICER Brockstedt Dirk G.

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 371d
  SEC Form 4 filed by Director Giordano Michael F

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 371d
  SEC Form 4 filed by Director Gray Mary Ann

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 371d
  SEC Form 4 filed by Director Lyons-Williams Lori

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 371d
  SEC Form 4 filed by Director Kozick Linda

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 432d
  SEC Form 4 filed by Director Robbins Wendye

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 432d
  SEC Form 4 filed by Director Gray Mary Ann

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 490d
  SEC Form 4 filed by CHIEF MEDICAL OFFICER Ho William

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 490d
  SEC Form 4 filed by CHIEF FINANCIAL OFFICER Young Rodney Kb

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 490d
  SEC Form 4 filed by CHIEF SCIENTIFIC OFFICER Brockstedt Dirk G.

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 490d
  SEC Form 4 filed by PRESIDENT AND CEO Wong Brian Russell

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 532d
  Former 10% Owner Column Group Ii, Lp disposed of 2,951,425 shares (SEC Form 4)

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 532d
  Former 10% Owner Column Group Ii, Lp disposed of 2,951,425 shares (SEC Form 4)

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 570d
  SEC Form 4 filed by CHIEF FINANCIAL OFFICER Young Rodney Kb

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 570d
  SEC Form 4 filed by PRESIDENT AND CEO Wong Brian Russell

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 570d
  SEC Form 4 filed by CHIEF MEDICAL OFFICER Ho William

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 570d
  SEC Form 4 filed by CHIEF SCIENTIFIC OFFICER Brockstedt Dirk G.

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 746d
  SEC Form 4 filed by Robbins Wendye

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 746d
  SEC Form 4 filed by Rieflin William Jl

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 746d
  SEC Form 4 filed by Lyons-Williams Lori

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 746d
  SEC Form 4 filed by Kozick Linda

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 746d
  SEC Form 4 filed by Gray Mary Ann

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 746d
  SEC Form 4 filed by Giordano Michael F

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 798d
  SEC Form 4 filed by Robbins Wendye

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 798d
  SEC Form 4 filed by Gray Mary Ann

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 798d
  SEC Form 4 filed by Rieflin William Jl

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 858d
  SEC Form 4 filed by Ho William

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 858d
  SEC Form 4 filed by Young Rodney Kb

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 858d
  SEC Form 4 filed by Brockstedt Dirk G.

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 858d
  SEC Form 4 filed by Wong Brian Russell

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 882d
  Brockstedt Dirk G. sold $20,456 worth of shares (898 units at $22.78), decreasing direct ownership by 3% to 27,820 units (SEC Form 4)

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 888d
  Brockstedt Dirk G. exercised 8,000 shares at a strike of $6.18, increasing direct ownership by 42% to 27,070 units (SEC Form 4)

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 900d
  Ho William sold $54,200 worth of shares (2,500 units at $21.68), decreasing direct ownership by 14% to 15,020 units (SEC Form 4)

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 923d
  Ho William sold $20,580 worth of shares (1,500 units at $13.72), decreasing direct ownership by 8% to 17,520 units (SEC Form 4)

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 978d
  Ho William sold $39,425 worth of shares (2,500 units at $15.77), decreasing direct ownership by 12% to 18,789 units (SEC Form 4)

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 1022d
  SEC Form 4: Ho William sold $47,300 worth of shares (2,500 units at $18.92), decreasing direct ownership by 11% to 21,289 units

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 1041d
  SEC Form 4: Ho William exercised 460 shares at a strike of $12.00, increasing direct ownership by 2% to 23,789 units

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 1078d
  SEC Form 4 filed by Ho William

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 1110d
  SEC Form 4 filed by Robbins Wendye

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 1110d
  SEC Form 4 filed by Rieflin William Jl

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)

Other RAPT categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends